A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada® for Pre-Exposure Prophylaxis (PrEP)
Clinical trial NCT01902472 · COMPLETED
Trial details
- NCT number
- NCT01902472
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-09-02
- Primary completion
- 2017-10-30
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.